Poop test could spot stomach cancer before it spreads

NCT ID NCT06943807

Recruiting now Diagnosis Sponsor: Fudan University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new way to screen for stomach cancer using a stool sample and a simple questionnaire. Researchers will enroll 15,000 people aged 40 and older to see if the fecal DNA test can find cancer earlier than current methods. Participants will provide a stool sample and answer questions about their risk, then undergo standard endoscopy for comparison.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: fecal multi-target DNA test
What this could lead to: If successful, this could provide a simple, non-invasive stool test to catch stomach cancer earlier, potentially improving survival rates.
What could go wrong: This is a screening study, not a treatment trial. The test may not be accurate enough, and results need confirmation via endoscopy. It is still early in evaluation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC (STOMACH) CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric cancer gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC (STOMACH) CANCER

Contacts and locations

Locations

People's Hospital of Tongling City
RECRUITING

Tongling, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.